CONMED Corporation (Nasdaq:CNMD)
April 16th, 2019
With markets going up CONMED Corporation finished Tuesday’s trading session down 3.02%, a ($2.52) decrease to close on $80.92. Despite the drop in price it hit a new 52 week high of $84.38. It’s expected that CONMED Corporation will report earnings within the next couple of weeks.
Analysis results from 4 analysts indicates that CONMED Corporation could fall somewhat (-3.52%), while Finbox has calculated (with low uncertainty) a fair value price of $80.61.
The market sectors were mixed Tuesday with a majority of the sectors trending up. Financials saw the biggest increase of the day (1.37%), while Real Estate saw the biggest drop (-2.38%). Information Technology has seen the biggest year-to-date gain at 23.78%.
Energy saw the biggest turnaround from its 5-day performance of -1.22%, as it went up 0.64%. Real Estate and Utilities saw turn arounds from their five day positive performance, Real Estate with a drop of -2.38%.
- Financials went up with a 1.37% change.
- Energy went up with a 0.64% change.
- Industrials went up with a 0.59% change.
- Information Technology went up with a 0.49% change.
- Consumer Discretionary went up with a 0.48% change.
- Materials went up with a 0.47% change.
- Communication Services went up with a 0.21% change.
- Consumer Staples went down with a -0.06% change.
- Utilities went down with a -1.39% change.
- Healthcare went down with a -2.03% change.
- Real Estate went down with a -2.38% change.
CONMED Corporation Info
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors; and VCARE uterine manipulator for enhancing the efficiency of laparoscopic hysterectomies and other gynecologic laparoscopic procedures. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician’s office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.
All amounts in USD unless otherwise indicated
Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.